New developments in perfusion imaging by bolus tracking

Journal of Neuroradiology

Volumn 32, Issue 5, 2005, Pages 315-320

  Ostergaard L ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Bolus tracking; CBF; CBV; MRI; MTT

Indexed keywords

CONTRAST MEDIUM;

ARTICLE; BLOOD VOLUME; BOLUS INJECTION; BRAIN BLOOD FLOW; BRAIN BLOOD VESSEL; BRAIN PERFUSION; CONTRAST ENHANCEMENT; NEUROIMAGING; THEORETICAL STUDY;

EID: 30044438154     PISSN: 01509861     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0150-9861(05)83160-8     Document Type: Article

References (46)

1. ALSOP D. Defining a local input function for perfusion quantification with bolus contrast MRI.: Proc ISMRM 2002.
2. ANDERSEN IK, SZYMKOWIAK A, RASMUSSEN CE, HANSON LG, MARSTRAND JR, LARSSON HBW et al. Perfusion quantification using Gaussian process deconvolution. Magn Reson Med 2002; 48 (2): 351-361.
3. BELLIVEAU JW, KENNEDY-DN J, MCKINSTRY RC, BUCHBINDER BR, WEISSKOEF RM, COHEN MS et al. Functional mapping of the human visual cortex by magnetic resonance imaging. Science 1991; 254 (5032): 716-719.
4. BOXERMAN JL, HAMBERG LM, ROSEN BR, WEISSKOFF RM. MR contrast due to intravascular magnetic susceptibility perturbations. Magn Reson Med 1995; 34 (4): 555-566.
5. BRONIKOWSKI TA, DAWSON CA, LINEHAN JH. Model-free deconvolution techniques for estimating vascular transport functions. Int J Biomed Comput 1983; 14 (5): 411-429.
6. CALAMANTE F, GADIAN DG, CONNELY A. Delay and dispersion effects in dynamic susceptibility contrast MRI: simulations using singular value decomposition. Magn Reson Med 2000; 466-473.
7. CRONE C. The permeability of capillaries in various organs as determined by use of the indicator diffusion method. Acta Physiol Scand 1963; 58: 292-305.
8. FISEL CR, ACKERMAN JL, BUXTON RB, GARRIDO L, BELLIVEAU JW, ROSEN BR et al. MR contrast due to microscopically heterogeneous magnetic susceptibility: numerical simulations and applications to cerebral physiology. Magn Reson Med 1991; 17 (2): 336-347.
9. GOBBEL GT, FIKE JR. A Deconvolution Method for Evaluating Indicator-Dilution Curves. Phys Med Biol 1994; 39: 1833-1854.
10. KISELEV VG, POSSE S. Analytical theory of susceptibility induced NMR signal dephasing in a cerebrovascular network. Phys Rev Lett 1998; 81: 5696-5699.
11. KISELEV VG, POSSE S. Analytical model of susceptibility-induced MR signal dephasing: effect of diffusion in a microvascular network. Magn Reson Med 1999; 41: 499-509.
12. KISELEV VG. On the Theoretical Basis of Perfusion Measurements by Dynamic Susceptibility Contrast MRI. Magn Reson Med 2001; 46: 1113-1122.
13. KING RB, RAYMOND GM, BASSINGTHWAIGHTE JB. Modeling blood flow heterogeneity. Ann Biomed Eng 1996; 24 (3): 352-372.
14. KING RB, DEUSSEN A, RAYMOND GM, BASSINGTHWAIGHTE JB. A vascular transport operator. Am J Physiol 1993; 265 (6 Pt 2): H2196-H2208.
15. LARSON KB, PERMAN WH, PERLMUTTER JS, GADO MH, ZIERLER KL. Tracer-kinetic analysis for measuring regional cerebral blood flow by dynamic nuclear magnetic resonance imaging. J Theor Biol 1994; 170 (1): 1-14.
16. LASSEN NA. Cerebral transit of an intravascular tracer may allow measurement of regional blood volume but not regional blood flow [letter]. J Cereb Blood Flow Metab 1984; 4 (4): 633-634.
17. LIU HL, PU Y, LIU Y, NICKERSON L, ANDREWS T, FOX PT et al. Cerebral blood flow measurement by dynamic contrast MRI using singular value decomposition with an adaptive threshold. Magn Reson Med 1999; 167-172.
18. MEIER P, ZIERLER KL. On the Theory of the Indicator-Dilution Method for Measurement of Blood Flow and Volume. J Appl Phys 1954; 6: 731-744.
19. ØSTERGAARD L, SMITH DF, VESTERGAARD-POULSEN P, HANSEN SB, GEE A, GJEDDE A et al. Absolute Cerebral Blood Flow and Blood Volume Measured by MRI Bolus Tracking: Comparison with PET Values. J Cereb Blood Flow Metab 1998; 18: 425-432.
20. ØSTERGAARD L, WEISSKOFF RM, CHESLER DA, GYLDENSTED C, ROSEN BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis. Magn Reson Med 1996; 36 (5): 715-725.
21. ØSTERGAARD L, CHESLER DA, WEISSKOFF RM, SORENSEN AG, ROSEN BR. Modeling cerebral blood flow and flow heterogeneity from magnetic resonance residue data. J Cereb Blood Flow Metab 1999; 19 (6): 690-699.
22. ØSTERGAARD L, JOHANNSEN P. HØST-POULSEN P, VESTERGAARD-POULSEN P, ASBOE H, GEE AD et al. Cerebral Blood Flow Measurements by MRI Bolus Tracking: Comparison with [15O] H2O PET in Humans. J Cereb Blood Flow Metab 1998; 18: 935-940.
23. PERKIÖ JP, ARONEN HJ, KANGASMAKI A, LIU Y, KARONEN JO, SAVOLAINEN S et al. Evaluation of four postprocessing methods for determination of cerebral blood volume and mean transit time by dynamic susceptibility contrast imaging. Magn Reson Med 2002; 47: 973-981.
24. REMPP KA, BRIX G, WENZ F, BECKER CR, GUCKEL F, LORENZ WJ. Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. Radiology 1994; 193 (3): 637-641.
25. RENKIN EM. Exchangeability of tissue potassium in skeletal muscle. Am J Physiol 1959; 197: 1211-1215.
26. ROSEN BR, BELLIVEAU JW, VEVEA JM, BRADY TJ. Perfusion imaging with NMR contrast agents. Magn Reson Med 1990; 14 (2): 249-265.
27. ROSEN BR, BELLIVEAU JW, BUCHBINDER BR, MCKINSTRY RC, PORKKA LM, KENNEDY DN et al. Contrast agents and cerebral hemodynamics. Magn Reson Med 1991; 19 (2): 285-292.
28. ROSEN BR, BELLIVEAU JW, ARONEN HJ, KENNEDY D, BUCHBINDER BR, FISCHMAN A et al. Susceptibility contrast imaging of cerebral blood volume: human experience. Magn Reson Med 1991; 22 (2): 293-299.
29. SCHREIBER WG, GUCKEL F, STRITZKE P, SCHMIEDEK P, SCHWARTZ A, BRIX G. Cerebral blood flow and cerebrovascular reserve capacity: estimation by dynamic magnetic resonance imaging. J Cereb Blood Flow Metab 1998; 18: 1143-1156.
30. SHIH LC, SAVER JL, ALGER JR, STARKMAN S, LEARY MC, VINUELA F et al. Perfusion-weighted magnetic resonance imaging thresholds identifying core, irreversibly infarcted tissue. Stroke 2003; 34 (6): 1425-1430.
31. SIMONSEN CZ, ØSTERGAARD L, VESTERGAARD-POULSEN P, RØHL L, BJØRNERUD A, GYLDENSTED C. CBF and CBV Measurements by USPIO Bolus Tracking: Reproducibility and Comparison with Gd-based Values. J Magn Reson Imaging 1999; 9: 342-347.
32. SMITH AM, GRANDIN CB, DUPREZ T, MATAIGNE F, COSNARD G. Whole brain quantitative CBF and CBV measurements using MRI bolus tracking: Comparison of methodologies. Magn Reson Med 2000; 43 (4): 559-564.
33. STEWART GN. Researches on the circulation time in organs and on the influences which affect it. Parts I-III. Journal of Physiology (London) 1894; 15: 1-89.
34. THOMPSON HK, STARMER F, WHALEN RE, MCINTOSH HD. Indicator Transit Time Considered as a Gamma Variate. Circ Res 1964; 14: 502-515.
35. VAN HUFFEL S, VANDEWALLE J, DE ROO MC, WILLEMS JL. Reliable and efficient deconvolution technique based on total linear least squares for calculating the renal retention function. Med Biol Eng Comput 1987; 25 (1): 26-33.
36. VILLRINGER A, ROSEN BR, BELLIVEAU JW, ACKERMAN JL, LAUFFER RB, BUXTON RB et al. Dynamic imaging with lanthanide chelates in normal brain: contrast due to magnetic susceptibility effects. Magn Reson Med 1988; 6 (2): 164-174.
37. VONKEN EP, BEEKMAN FJ, BAKKER CJ, VIERGEVER MA. Maximum likelihood estimation of cerebral blood flow in dynamic susceptibility contrast MRI. Magn Reson Med 1999; 41: 343-350.
38. VONKEN EJPA, VAN OSCH MJP, BAKKER CJG, VIERGEVER MA. Measurement of cerebral perfusion with dual-echo multi-slice quantitative dynamic susceptibility contrast MRI. Jmri-Journal of Magnetic Resonance Imaging 1999; 10 (2): 109-117.
39. WEISSKOFF RM, ZUO CS, BOXERMAN JL, ROSEN BR. Microscopic susceptibility variation and transverse relaxation: theory and experiment. Magn Reson Med 1994; 31 (6): 601-610.
40. WEISSKOFF RM, CHESLER D, BOXERMAN JL, ROSEN BR. Pitfalls in MR measurement of tissue blood flow with intravascular tracers: which mean transit time? Magn Reson Med 1993; 29 (4): 553-558.
41. WIRESTAM R, ANDERSSON L, ØSTERGAARD L, BOLLING M, AUNOLA JP, LINDGREN A et al. Assessment of regional cerebral blood flow by dynamic susceptibility contrast MRI using different deconvolution techniques. Magn Reson Med 2000; 43: 691-700.
42. WU O, OSTERGAARD L, KOROSHETZ WJ, SCHWAMM LH, O'DONNELL J, SCHAEFER PW et al. Effects of tracer arrival time on flow estimates in MR perfusion-weighted imaging. Magn Reson Med 2003; 50 (4): 856-864.
43. WU O, ØSTERGAARD L, WEISSKOFF RM, BENNER T, ROSEN BR, SORENSEN AG. Tracer arrival timing-insensitive technique or estimating flow in MR perfusion-weighted imaging using singular value decomposition with a block-circulant deconvolution Matrix. Magn Reson Med 2003; 50: 100-110.
44. YAMADA K, WU O, GONZALEZ RG, BAKKER D, ØSTERGAARD L, COPEN WA et al. Magnetic resonance perfusion-weighted imaging of acute cerebral infarction: effect of the calculation methods and underlying vasculopathy. Stroke 2002; 33: 87-94.
45. ZIERLER KL. Equations for Measuring Blood Flow by External Monitoring of Radioisotopes. Circ Res 1965; 16: 309-321.
46. ZIERLER KL. Theoretical Basis of Indicator-Dilution Methods for Measuring Flow and Volume. Circ Res 1962; 10: 393-407.